The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr. Ashvin Agarwal & Dr. Ashar Agarwal
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Ashvin Agarwal, a promoter of Dr. Agarwals Health Care Ltd, transferred 9,40,578 shares (0.30% of equity) to fellow promoter Dr. Ashar Agarwal via an inter-se gift transfer on December 4, 2025. After the transfer, Dr. Ashvin Agarwal's holding fell from 4.76% (1,50,44,121 shares) to 4.46% (1,41,03,543 shares). Both transferor and acquirer belong to the promoter group, so the total promoter shareholding of the company remains unchanged. The company's total equity share capital stands at 31,61,70,880 shares of Re. 1 each.
This is a routine internal promoter-family reshuffle with zero change in total promoter ownership or voting power, so it is unlikely to have any material impact on the stock price. Investors may treat this as a non-event.